BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 7657517)

  • 21. Differential expression of matrilysin-1 (MMP-7), 92 kD gelatinase (MMP-9), and metalloelastase (MMP-12) in oral verrucous and squamous cell cancer.
    Impola U; Uitto VJ; Hietanen J; Hakkinen L; Zhang L; Larjava H; Isaka K; Saarialho-Kere U
    J Pathol; 2004 Jan; 202(1):14-22. PubMed ID: 14694517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modifying the soil to affect the seed: role of stromal-derived matrix metalloproteinases in cancer progression.
    Jodele S; Blavier L; Yoon JM; DeClerck YA
    Cancer Metastasis Rev; 2006 Mar; 25(1):35-43. PubMed ID: 16680570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of matrix metalloproteinases in melanoma cell invasion.
    Hofmann UB; Houben R; Bröcker EB; Becker JC
    Biochimie; 2005; 87(3-4):307-14. PubMed ID: 15781317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcriptional suppression of matrix metalloproteinase-2 gene expression in human astroglioma cells by TNF-alpha and IFN-gamma.
    Qin H; Moellinger JD; Wells A; Windsor LJ; Sun Y; Benveniste EN
    J Immunol; 1998 Dec; 161(12):6664-73. PubMed ID: 9862695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Melanoma-mediated dissolution of extracellular matrix: contribution of urokinase-dependent and metalloproteinase-dependent proteolytic pathways.
    Montgomery AM; De Clerck YA; Langley KE; Reisfeld RA; Mueller BM
    Cancer Res; 1993 Feb; 53(3):693-700. PubMed ID: 8425205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The other side of MMPs: protective roles in tumor progression.
    Martin MD; Matrisian LM
    Cancer Metastasis Rev; 2007 Dec; 26(3-4):717-24. PubMed ID: 17717634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of matrix, fibroblasts and type IV collagenases in tumor progression and invasion.
    Noël A; Emonard H; Polette M; Birembaut P; Foidart JM
    Pathol Res Pract; 1994 Oct; 190(9-10):934-41. PubMed ID: 7899143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
    Slaton JW; Karashima T; Perrotte P; Inoue K; Kim SJ; Izawa J; Kedar D; McConkey DJ; Millikan R; Sweeney P; Yoshikawa C; Shuin T; Dinney CP
    Clin Cancer Res; 2001 Sep; 7(9):2840-53. PubMed ID: 11555602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Matrix invasion by tumour cells: a focus on MT1-MMP trafficking to invadopodia.
    Poincloux R; Lizárraga F; Chavrier P
    J Cell Sci; 2009 Sep; 122(Pt 17):3015-24. PubMed ID: 19692588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-invasive activity of ursolic acid correlates with the reduced expression of matrix metalloproteinase-9 (MMP-9) in HT1080 human fibrosarcoma cells.
    Cha HJ; Bae SK; Lee HY; Lee OH; Sato H; Seiki M; Park BC; Kim KW
    Cancer Res; 1996 May; 56(10):2281-4. PubMed ID: 8625299
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Independent regulation of matrix metalloproteinases and plasminogen activators in human fibrosarcoma cells.
    Lim YT; Sugiura Y; Laug WE; Sun B; Garcia A; DeClerck YA
    J Cell Physiol; 1996 May; 167(2):333-40. PubMed ID: 8613475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spectrum of matrix metalloproteinase expression in primary and metastatic colon cancer: relationship to the tissue inhibitors of metalloproteinases and membrane type-1-matrix metalloproteinase.
    Collins HM; Morris TM; Watson SA
    Br J Cancer; 2001 Jun; 84(12):1664-70. PubMed ID: 11401321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies.
    Folgueras AR; Pendás AM; Sánchez LM; López-Otín C
    Int J Dev Biol; 2004; 48(5-6):411-24. PubMed ID: 15349816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Collagenases and cancers].
    Hérédia A; Burtin P
    Pathol Biol (Paris); 1988 Nov; 36(9):1147-50. PubMed ID: 2851769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Matrix metalloproteinases: Promoters of tumor invasion and metastasis - A review with focus on gastrointestinal tumors].
    Roeb E; Matern S
    Z Gastroenterol; 2001 Sep; 39(9):807-13. PubMed ID: 11558074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Matrix metalloproteinases in tumor invasion.
    Johansson N; Ahonen M; Kähäri VM
    Cell Mol Life Sci; 2000 Jan; 57(1):5-15. PubMed ID: 10949577
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer cells, adipocytes and matrix metalloproteinase 11: a vicious tumor progression cycle.
    Motrescu ER; Rio MC
    Biol Chem; 2008 Aug; 389(8):1037-41. PubMed ID: 18979628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sequential production and activation of matrix-metalloproteinase-9 (MMP-9) with breast cancer progression.
    Rha SY; Kim JH; Roh JK; Lee KS; Min JS; Kim BS; Chung HC
    Breast Cancer Res Treat; 1997 Apr; 43(2):175-81. PubMed ID: 9131273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of collagenases in tumor cell invasion.
    Liotta LA; Thorgeirsson UP; Garbisa S
    Cancer Metastasis Rev; 1982; 1(4):277-88. PubMed ID: 6309368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Anti-tumoral matrikines: potential interest in oncology].
    Maquart FX
    Bull Acad Natl Med; 2010 Mar; 194(3):633-45; discussion 645-6. PubMed ID: 21171255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.